Which accessible clinical features and laboratory findings might predict methotrexate success in children with juvenile idiopathic arthritis in Bosnia and Herzegovina?

Autor: Adisa Čengić, Velma Selmanović, Sniježana Hasanbegović, Hamza Izeta, Lamija Zečević, Nejra Džananović

Publikováno v: Medicinski Glasnik, Vol 22, Iss 1 (2025)

Aim To determine whether demographic data, clinical features, and laboratory variables at disease onset can predict the response to methotrexate in juvenile idiopathic arthritis (JIA) patients. Methods A cohort of 143 newly diagnosed JIA patients ini

Externí odkaz: https://doaj.org/article/4720e18874264fe8abf4e0f4f5bec102

HLA-DRB1*01 predicts treatment outcome in juvenile idiopathic arthritis: A retrospective-prospective cohort study.

Autor: Čengić A; Paediatric Clinic, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Hasanbegović S; Paediatric Clinic, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Hamza I; Health Centre of Canton Sarajevo, Sarajevo, Bosnia and Herzegovina., Suljić T; Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Selmanović V; Paediatric Clinic, Clinical Centre University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Đozo A; Institute for Transfusion Medicine of the Federation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina., Fejzić E; Institute for Transfusion Medicine of the Federation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina., Zečević-Pašić L; Clinical Immunology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Džananović N; Clinical Immunology, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.

Publikováno v: Biomolecules & biomedicine [Biomol Biomed] 2024 Oct 31. Date of Electronic Publication: 2024 Oct 31.